John D. Zehren
Director/Miembro de la Junta en Singlepass, Inc. .
Cargos activos de John D. Zehren
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Singlepass, Inc.
 Singlepass, Inc. Medical SpecialtiesHealth Technology Singlepass, Inc. has developed a unique electrocautery device that improves the clinical outcomes of deep tissue biopsy procedures. The company is based in Lake Forest, CA. The patented, single-use device prevents and stops bleeding caused by tissue extraction by cauterizing the tissue channel. It is the only cautery device of its kind that can be used for biopsy procedures. Singlepass was founded by Peter Sunenshine and Kevin Hirsch. The CEO is Bill Colone. | Director/Miembro de la Junta | 18/03/2022 | - |
| Independent Dir/Board Member | 18/03/2022 | - |
Historial de carrera de John D. Zehren
Antiguos cargos conocidos de John D. Zehren.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ENDOLOGIX, INC. | Corporate Officer/Principal | 07/01/2019 | 14/04/2020 |
Formación de John D. Zehren.
| University of St. Thomas | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
Operativa
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
| Director/Board Member | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Endologix LLC
 Endologix LLC Medical SpecialtiesHealth Technology Endologix LLC engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA. | Health Technology |
Singlepass, Inc.
Singlepass, Inc. Medical SpecialtiesHealth Technology Singlepass, Inc. has developed a unique electrocautery device that improves the clinical outcomes of deep tissue biopsy procedures. The company is based in Lake Forest, CA. The patented, single-use device prevents and stops bleeding caused by tissue extraction by cauterizing the tissue channel. It is the only cautery device of its kind that can be used for biopsy procedures. Singlepass was founded by Peter Sunenshine and Kevin Hirsch. The CEO is Bill Colone. | Health Technology |
- Bolsa de valores
- Insiders
- John D. Zehren
- Experiencia
